Abstract
assessment of hepatic fibrosis that is validated in patients with non-cardiac hepatic dysfunction. The aim of our study was to assess the agreement of VCTE with Lbx for assessment of fibrosis stage in patients undergoing evaluation for HT or LVAD. Methods: Patients scheduled to undergo Lbx during evaluation for HT or LVAD were eligible for our prospective study. Enrolled patients had VCTE exam shortly after Lbx was performed. Stage of fibrosis assessed by VCTE was compared to the Lbx. Pertinent clinical, laboratory and hemodynamic data was abstracted. Results: Six patients completed study protocol between January and September of 2015. Relevant clinical information and VCTE and Lbx results are presented in Table. Stage of hepatic fibrosis assessed by histopathology and VCTE correlated in one patient and was discrepant in five. Conclusion: VCTE correlated within 1 fibrosis stage in half of the patients, and consistently overestimated the presence of hepatic fibrosis. VCTE may be useful to avoid Lbx in some patients with AHF but larger studies are needed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
